LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 CP724714
0.12
uM
LJP5
 0.5819 0.0446 0.2945 0.1137
SK-BR-3 CP466722
0.12
uM
LJP5
 1.0477 0.0175 1.0811 0.0301
SK-BR-3 Crizotinib
0.12
uM
LJP5
 0.8931 0.0235 0.8180 0.0463
SK-BR-3 Momelotinib
0.12
uM
LJP5
 0.8894 0.0548 0.8107 0.0920
SK-BR-3 Dasatinib
0.12
uM
LJP5
 1.0185 0.0235 1.0262 0.0376
SK-BR-3 Dasatinib
0.12
uM
LJP6
 0.9080 0.0030 0.8461 0.0141
SK-BR-3 Dovitinib
0.12
uM
LJP5
 0.7916 0.0146 0.6532 0.0283
SK-BR-3 Enzastaurin
0.12
uM
LJP5
 1.0677 0.0392 1.1161 0.0653
SK-BR-3 Erlotinib
0.12
uM
LJP5
 0.9386 0.0280 0.9015 0.0455
SK-BR-3 Foretinib
0.12
uM
LJP5
 0.9006 0.0987 0.8288 0.1620
SK-BR-3 R406
0.12
uM
LJP6
 0.9644 0.0199 0.9390 0.0364
SK-BR-3 Pictilisib
0.12
uM
LJP6
 0.5515 0.0100 0.2532 0.0417
SK-BR-3 Gefitinib
0.12
uM
LJP6
 0.8232 0.0111 0.7036 0.0330
SK-BR-3 Geldanamycin
0.12
uM
LJP5
 0.3638 0.0092 -0.0619 0.0755
SK-BR-3 Geldanamycin
0.12
uM
LJP6
 0.3610 0.0057 -0.0640 0.0534
SK-BR-3 GSK1059615
0.12
uM
LJP5
 0.9617 0.0377 0.9427 0.0565
SK-BR-3 GSK1059615
0.12
uM
LJP6
 0.7961 0.0104 0.6582 0.0375
SK-BR-3 GSK1904529A
0.12
uM
LJP6
 0.8812 0.0128 0.8021 0.0232
SK-BR-3 Omipalisib
0.12
uM
LJP6
 0.3368 0.0252 -0.1067 0.0882
SK-BR-3 GSK 690693
0.12
uM
LJP5
 0.7236 0.0255 0.5438 0.0237
SK-BR-3 GW843682X
0.12
uM
LJP6
 0.6434 0.0824 0.4209 0.1108
SK-BR-3 HG-5-113-01
0.12
uM
LJP5
 0.8841 0.0573 0.8050 0.0956
SK-BR-3 HG-5-88-01
0.12
uM
LJP6
 0.7939 0.0217 0.6522 0.0570
SK-BR-3 Imatinib
0.12
uM
LJP6
 1.0354 0.0269 1.0537 0.0419
SK-BR-3 JNK-9L
0.12
uM
LJP6
 0.8116 0.0433 0.6901 0.0684